Evidence map›Paper›PMID 28645852›Full record

ReviewBiochimica et biophysica acta. Molecular and cell biology of lipids2017

G0S2: A small giant controller of lipolysis and adipose-liver fatty acid flux.

Xiaodong Zhang, Bradlee L Heckmann, Latoya E Campbell, Jun Liu

Open access · greenAbstract readReview
In one paragraph

Review in Biochimica et biophysica acta. Molecular and cell biology of lipids, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 93 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Xiaodong ZhangDepartment of Biochemistry & Molecular Biology, Mayo Clinic College of Medicine, Scottsdale, AZ, United States; HEAL(th) Program, Mayo Clinic, Scottsdale, AZ, United States.
Bradlee L HeckmannDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, United States.
Latoya E CampbellSchool of Life Sciences, Arizona State University, Tempe, AZ, United States.
Jun LiuDepartment of Biochemistry & Molecular Biology, Mayo Clinic College of Medicine, Scottsdale, AZ, United States; HEAL(th) Program, Mayo Clinic, Scottsdale, AZ, United States; Division of Endocrinology, Mayo Clinic, Scottsdale, AZ, United States. Electronic address: liu.jun@mayo.edu.
Mayo Clinic in Arizona · USArizona State University · USSt. Jude Children's Research Hospital · US

Funding

Graduate and Undergraduate Training in Biomedicine at ASUR25GM099650 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI NEWFELD, STUART J · 2012 to 2015
$2.2M
Inhibition of ATGL-Mediated Lipolysis by G0S2R01DK089178 · NIDDK · UNIVERSITY OF KENTUCKY · PI LIU, JUN · 2010 to 2014
$1.7M
Regulation of Hepatic Lipid Accumulation and Insulin ResistanceR01DK109096 · NIDDK · MAYO CLINIC ROCHESTER · PI LIU, JUN · 2016 to 2019
$1.5M
G0S2: a dual-function regulator of lipid and energy metabolismR56DK089178 · NIDDK · MAYO CLINIC ARIZONA · PI LIU, JUN · 2015 to 2015
$125k
NIDDK NIH HHS R01 DK089178NIDDK NIH HHS R01 DK109096NIDDK NIH HHS R56 DK089178NIGMS NIH HHS R25 GM099650
6 · The paper itself

Abstract

The discovery of adipose triglyceride lipase (ATGL) and its coactivator comparative gene identification-58 (CGI-58) provided a major paradigm shift in the understanding of intracellular lipolysis in both adipocytes and nonadipocyte cells. The subsequent discovery of G0/G1 switch gene 2 (G0S2) as a potent endogenous inhibitor of ATGL revealed a unique mechanism governing lipolysis and fatty acid (FA) availability. G0S2 is highly conserved in vertebrates, and exhibits cyclical expression pattern between adipose tissue and liver that is critical to lipid flux and energy homeostasis in these two tissues. Biochemical and cell biological studies have demonstrated that a direct interaction with ATGL mediates G0S2's inhibitory effects on lipolysis and lipid droplet degradation. In this review we examine evidence obtained from recent in vitro and in vivo studies that lends support to the proof-of-principle concept that G0S2 functions as a master regulator of tissue-specific balance of TG storage vs. mobilization, partitioning of metabolic fuels between adipose and liver, and the whole-body adaptive energy response. This article is part of a Special Issue entitled: Recent Advances in Lipid Droplet Biology edited by Rosalind Coleman and Matthijs Hesselink.

Indexed as

AcyltransferasesAdipose TissueAnimalsCell Cycle ProteinsEnergy MetabolismFatty AcidsHumansLipaseLipid DropletsLipolysisLiverOrgan SpecificityTriglyceridesAcyltransferasesCell Cycle ProteinsFatty AcidsG0S2 protein, humanLipasePNPLA2 protein, humanTriglyceridesATGLFatty acidG0S2Lipid dropletLipolysisTriglyceride

Identifiers

PMID28645852
PMCPMC5890940
OpenAlexW2666352856

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.